Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Woodcock Wants Rapid Regulatory Policy Development

May 22 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Woodcock, Califf Give Thumbs Up To Certain 21<sup>st</sup> Century Cures Provisions

Dec 15 2016

Label Expansion: Could Clinical Experience Data Find Supplement Work-Around?

Apr 20 2017

Gottlieb Promotes 'Bottom-Up' Review To Increase FDA Efficiency, Consistency

Apr 07 2017

Breakthrough-Style Program For ANDAs Added To House User Fee Bill

May 19 2017

You Just Have To Wait: FDA Can't Hurry PDUFA VI Guidances

Aug 15 2016

CDER Director Woodcock Plans Changes To Drug Reviews During OND Transition

Mar 07 2017

Interchangeability: FDA Sets ‘Stringent’ Standard On Design Differences

Jan 24 2017

FDA's Document Dump: Guidance Release Skyrockets Ahead Of Trump's Arrival

Jan 22 2017

Additional Topics

United States FDA Regulation Biosimilars BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window